Sight Sciences, Inc. (SGHT): Cash & Equivalents

Annual figures by period end, from SEC filings.

$91.97M
As of 2025-12-31
$79.75M
As of 2026-06-30
-20.8%
3-year compound annual growth
+8.4%
5-year compound annual growth
$260.69M2020-12-31: $61.51M2021-12-31: $260.69M2022-12-31: $185.00M2023-12-31: $138.13M2024-12-31: $120.36M2025-12-31: $91.97M$91.97M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$91.97M-23.6%2026-03-04, Balance as of period end
2024-12-31$120.36M-12.9%2026-03-04, Balance as of period end
2023-12-31$138.13M-25.3%2025-03-07, Balance as of period end
2022-12-31$185.00M-29.0%2024-03-13, Balance as of period end
2021-12-31$260.69M+323.8%2023-03-16, Balance as of period end
2020-12-31$61.51Mn/a2022-03-24, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Sight Sciences, Inc. (SGHT)2025-12-31$91.97M-23.6%
PRO DEX Inc (PDEX)2026-06-30$8.19Mn/m
TELA Bio, Inc. (TELA)2025-12-31$50.84M-3.5%
AVITA Medical, Inc. (RCEL)2025-12-31$10.24M-27.1%
Iradimed Corp (IRMD)2025-12-31$51.16M-2.1%
Delcath Systems, Inc. (DCTH)2025-12-31$43.45M+34.1%
Pulmonx Corp (LUNG)2025-12-31$69.75M-1.6%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$99.71M-58.0%
NeuroPace Inc (NPCE)2025-12-31$21.69M+61.5%

Compare SGHT, PDEX, TELA, RCEL side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗